John L.  Brottem net worth and biography

John Brottem Biography and Net Worth

General Counsel of Outset Medical
John Brottem joined Outset as General Counsel in May 2020. He brings nearly two decades of experience leading legal teams within the healthcare and technology industries. John joined the company from Omnicell where he most recently served as Vice President and Deputy General Counsel. At Omnicell John was involved in a range of activities including public company reporting, corporate governance, M&A and strategic transactions, sales and marketing support, compliance, regulatory, IP and litigation. He previously served as corporate counsel at Brocade Communications Systems and Foundry Networks, and spent six years as an associate in the business department of Cooley LLP.
John received his undergraduate degree from Occidental College and his JD from the University of California, Davis, School of Law.

What is John L. Brottem's net worth?

The estimated net worth of John L. Brottem is at least $219.46 thousand as of November 17th, 2025. Mr. Brottem owns 46,495 shares of Outset Medical stock worth more than $219,456 as of December 5th. This net worth approximation does not reflect any other investments that Mr. Brottem may own. Additionally, Mr. Brottem receives a salary of $594,150.00 as General Counsel at Outset Medical. Learn More about John L. Brottem's net worth.

How old is John L. Brottem?

Mr. Brottem is currently 49 years old. There are 5 older executives and no younger executives at Outset Medical. The oldest executive at Outset Medical is Mr. Mark Gordon M.S., Chief Regulatory & Quality Officer, who is 67 years old. Learn More on John L. Brottem's age.

What is John L. Brottem's salary?

As the General Counsel of Outset Medical, Inc., Mr. Brottem earns $594,150.00 per year. There are 2 executives that earn more than Mr. Brottem. The highest earning executive at Outset Medical is Ms. Leslie L. Trigg, President, CEO & Chairman, who commands a salary of $1,220,000.00 per year. Learn More on John L. Brottem's salary.

How do I contact John L. Brottem?

The corporate mailing address for Mr. Brottem and other Outset Medical executives is 3052 ORCHARD DRIVE, SAN JOSE CA, 95134. Outset Medical can also be reached via phone at 669-231-8200 and via email at [email protected]. Learn More on John L. Brottem's contact information.

Has John L. Brottem been buying or selling shares of Outset Medical?

During the last ninety days, John L. Brottem has sold $1,784.80 in Outset Medical stock. Most recently, John L. Brottem sold 388 shares of the business's stock in a transaction on Monday, November 17th. The shares were sold at an average price of $4.60, for a transaction totalling $1,784.80. Following the completion of the sale, the general counsel now directly owns 46,495 shares of the company's stock, valued at $213,877. Learn More on John L. Brottem's trading history.

Who are Outset Medical's active insiders?

Outset Medical's insider roster includes Nabeel Ahmed (VP), John Brottem (General Counsel), Rebecca Chambers (CFO), D. Grossman (Director), James Hinrichs (Director), Marc Nash (SVP), Leslie Trigg (CEO), Martin Vazquez (COO), and Steven Williamson (Insider). Learn More on Outset Medical's active insiders.

Are insiders buying or selling shares of Outset Medical?

In the last year, insiders at the sold shares 23 times. They sold a total of 24,777 shares worth more than $297,113.91. The most recent insider tranaction occured on December, 1st when Director Karen Drexler sold 1,548 shares worth more than $6,764.76. Insiders at Outset Medical own 2.4% of the company. Learn More about insider trades at Outset Medical.

Information on this page was last updated on 12/1/2025.

John L. Brottem Insider Trading History at Outset Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/17/2025Sell388$4.60$1,784.8046,495View SEC Filing Icon  
5/15/2025Sell396$17.82$7,056.7211,273View SEC Filing Icon  
2/18/2025Sell409$13.50$5,521.5011,669View SEC Filing Icon  
1/21/2025Sell2,195$12.00$26,340.0012,079View SEC Filing Icon  
1/13/2025Sell1,366$12.15$16,596.9013,668View SEC Filing Icon  
1/7/2025Sell104$19.35$2,012.4015,034View SEC Filing Icon  
11/15/2024Sell213$12.00$2,556.0015,139View SEC Filing Icon  
8/15/2024Sell200$12.60$2,520.0015,353View SEC Filing Icon  
5/16/2024Sell198$52.95$10,484.1016,258View SEC Filing Icon  
2/15/2024Sell222$53.55$11,888.1016,336View SEC Filing Icon  
1/16/2024Sell98$64.35$6,306.3016,559View SEC Filing Icon  
1/8/2024Sell489$82.35$40,269.153,253View SEC Filing Icon  
7/19/2023Sell94$300.00$28,200.003,929View SEC Filing Icon  
6/20/2023Sell94$329.55$30,977.703,929View SEC Filing Icon  
5/17/2023Sell182$301.20$54,818.403,929View SEC Filing Icon  
5/3/2023Sell94$300.00$28,200.004,106View SEC Filing Icon  
3/20/2023Sell275$312.30$85,882.504,106View SEC Filing Icon  
2/16/2023Sell90$365.40$32,886.004,428View SEC Filing Icon  
1/27/2023Sell285$418.80$119,358.004,518View SEC Filing Icon  
11/30/2022Sell850$305.10$259,335.002,069View SEC Filing Icon  
11/18/2022Sell127$285.00$36,195.002,069View SEC Filing Icon  
8/16/2022Sell23$322.20$7,410.602,220View SEC Filing Icon  
5/17/2022Sell23$395.40$9,094.202,244View SEC Filing Icon  
4/18/2022Sell161$648.75$104,448.752,267View SEC Filing Icon  
3/17/2022Sell93$606.90$56,441.70View SEC Filing Icon  
3/15/2022Sell439$578.85$254,115.15View SEC Filing Icon  
3/1/2022Sell66$655.95$43,292.70View SEC Filing Icon  
2/15/2022Sell666$538.80$358,840.80View SEC Filing Icon  
1/18/2022Sell666$534.15$355,743.90View SEC Filing Icon  
1/3/2022Sell166$705.75$117,154.50View SEC Filing Icon  
12/1/2021Sell233$718.80$167,480.40View SEC Filing Icon  
11/15/2021Sell329$771.00$253,659.00View SEC Filing Icon  
10/19/2021Sell96$750.00$72,000.00View SEC Filing Icon  
10/15/2021Sell233$735.30$171,324.90View SEC Filing Icon  
9/15/2021Sell329$755.25$248,477.25View SEC Filing Icon  
9/7/2021Sell192$750.00$144,000.00View SEC Filing Icon  
8/16/2021Sell233$580.20$135,186.601,211View SEC Filing Icon  
7/15/2021Sell233$657.45$153,185.851,211View SEC Filing Icon  
6/17/2021Sell96$750.00$72,000.001,074View SEC Filing Icon  
6/15/2021Sell233$718.05$167,305.651,211View SEC Filing Icon  
5/17/2021Sell233$635.10$147,978.301,211View SEC Filing Icon  
4/15/2021Sell233$812.55$189,324.151,211View SEC Filing Icon  
3/18/2021Sell233$715.65$166,746.451,211View SEC Filing Icon  
See Full Table

John L. Brottem Buying and Selling Activity at Outset Medical

This chart shows John L Brottem's buying and selling at Outset Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Outset Medical Company Overview

Outset Medical logo
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Read More

Today's Range

Now: $4.72
Low: $4.16
High: $4.79

50 Day Range

MA: $10.54
Low: $4.05
High: $15.81

2 Week Range

Now: $4.72
Low: $4.00
High: $25.35

Volume

627,131 shs

Average Volume

814,952 shs

Market Capitalization

$85.67 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.03